| Nov 13 |
SoundHound AI plunges despite reporting record quarterly revenue
|
| Nov 12 |
Tempus AI: Pioneering The Future Of Precision Medicine Through AI-Driven Innovation
|
| Nov 12 |
Tempus Molecular Profiling Integration Now Available Through Flatiron’s OncoEMR®
|
| Nov 11 |
Tempus AI downgraded to hold by Stifel, valuation cited
|
| Nov 11 |
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
|
| Nov 11 |
Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session
|
| Nov 11 |
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
|
| Nov 9 |
Tempus AI, Inc. (TEM) Q3 2024 Earnings Call Transcript
|
| Nov 9 |
Tempus AI, Inc 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 8 |
Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting
|
